These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17593202)

  • 1. Assessing the attitudes to prostate cancer treatment among European male patients.
    Schulman C
    BJU Int; 2007 Jul; 100 Suppl 1():6-11. PubMed ID: 17593202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of the urologist and nurse from the perspective of patients with prostate cancer receiving luteinizing hormone-releasing hormone analogue therapy.
    Lebret T; Bouregba A
    BJU Int; 2008 Nov; 102(10):1419-24. PubMed ID: 18549431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Confidence in the ability to communicate with physicians among low-income patients with prostate cancer.
    Maliski SL; Kwan L; Krupski T; Fink A; Orecklin JR; Litwin MS
    Urology; 2004 Aug; 64(2):329-34. PubMed ID: 15302489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of providing audiotapes of primary treatment consultations to men with prostate cancer: a multi-site, randomized, controlled trial.
    Hack TF; Pickles T; Bultz BD; Ruether JD; Degner LF
    Psychooncology; 2007 Jun; 16(6):543-52. PubMed ID: 16991107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum testosterone recovery after cessation of long-term luteinizing hormone-releasing hormone agonist in patients with prostate cancer.
    Bong GW; Clarke HS; Hancock WC; Keane TE
    Urology; 2008 Jun; 71(6):1177-80. PubMed ID: 18279929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PCA: prostate cancer, patient-centred approach or both?
    Denis L; Joniau S; Bossi A; Baskin-Bey E; Fitzpatrick JM
    BJU Int; 2012 Jul; 110(1):16-22. PubMed ID: 22233268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equivalent and sufficient effects of leuprolide acetate and goserelin acetate to suppress serum testosterone levels in patients with prostate cancer.
    Fujii Y; Yonese J; Kawakami S; Yamamoto S; Okubo Y; Fukui I
    BJU Int; 2008 May; 101(9):1096-100. PubMed ID: 18190637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychosocial barriers to active surveillance for the management of early prostate cancer and a strategy for increased acceptance.
    Pickles T; Ruether JD; Weir L; Carlson L; Jakulj F;
    BJU Int; 2007 Sep; 100(3):544-51. PubMed ID: 17532857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'As long as the doctors know what they are doing': trust or ambivalence about patient information among elderly men with prostate cancer?
    Bungay H; Cappello R
    Eur J Cancer Care (Engl); 2009 Sep; 18(5):470-6. PubMed ID: 19473376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attitudes of prostate cancer patients towards the diagnosis and treatment of their disease: findings from a multinational survey.
    Hardy C; Penn S; Morris T
    Curr Med Res Opin; 2007 Sep; 23(9):2107-16. PubMed ID: 17651536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Information needs of men with prostate cancer and their partners].
    Krol Y; van Dam FS; Horenblas S; Meinhardt W; Muller MJ
    Ned Tijdschr Geneeskd; 2000 Feb; 144(9):431-7. PubMed ID: 10719548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent androgen deprivation for locally advanced and metastatic prostate cancer: results from a randomised phase 3 study of the South European Uroncological Group.
    Calais da Silva FE; Bono AV; Whelan P; Brausi M; Marques Queimadelos A; Martin JA; Kirkali Z; Calais da Silva FM; Robertson C
    Eur Urol; 2009 Jun; 55(6):1269-77. PubMed ID: 19249153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer.
    Klotz L; Boccon-Gibod L; Shore ND; Andreou C; Persson BE; Cantor P; Jensen JK; Olesen TK; Schröder FH
    BJU Int; 2008 Dec; 102(11):1531-8. PubMed ID: 19035858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Auricular acupuncture: a novel treatment for vasomotor symptoms associated with luteinizing-hormone releasing hormone agonist treatment for prostate cancer.
    Harding C; Harris A; Chadwick D
    BJU Int; 2009 Jan; 103(2):186-90. PubMed ID: 18710455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Men, masculinities, and prostate cancer: Australian and Canadian patient perspectives of communication with male physicians.
    Oliffe J; Thorne S
    Qual Health Res; 2007 Feb; 17(2):149-61. PubMed ID: 17220387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer.
    Davison BJ; Oliffe JL; Pickles T; Mroz L
    Oncol Nurs Forum; 2009 Jan; 36(1):89-96. PubMed ID: 19136342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-centred care: What are the experiences of prostate cancer patients and their partners?
    Sinfield P; Baker R; Agarwal S; Tarrant C
    Patient Educ Couns; 2008 Oct; 73(1):91-6. PubMed ID: 18565717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen deprivation therapy for prostate cancer: effects on hand function.
    Soyupek F; Soyupek S; Perk H; Ozorak A
    Urol Oncol; 2008; 26(2):141-6. PubMed ID: 18312932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age, health, and education determine supportive care needs of men younger than 70 years with prostate cancer.
    Smith DP; Supramaniam R; King MT; Ward J; Berry M; Armstrong BK
    J Clin Oncol; 2007 Jun; 25(18):2560-6. PubMed ID: 17577034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.